Physician profile
Mark A Dwight
NPI 1851491989
$1,456.36
in general payments reported to CMS, 2019-2025
21 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $302 · 2021: $15.91 · 2022: $50.66 · 2023: $128 · 2024: $50.77 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $310.37 | 2019-2020 | |
| Therapeuticsmd, INC. | $151.86 | 2019-2020 | |
| Avion Pharmaceuticals | $146.76 | 2019-2020 | |
| Coopersurgical, INC. | $142.18 | 2023-2025 | Summit Doppler, Sos |
| Hologic Sales and Service, LLC | $123.70 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $117.76 | 2019-2024 | |
| Allergan, INC. | $61.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $58.58 | 2019-2025 | Gardasil 9 |
| Aspira Women'S Health INC | $46.98 | 2020 | |
| Coloplast Corp | $37.90 | 2019 | |
| Lupin INC. | $37.27 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $29.06 | 2025 | |
| Supernus Pharmaceuticals, INC. | $26.17 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $26.17 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $21.91 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.75 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $20.94 | 2025 | |
| Astellas Pharma US INC | $20.71 | 2024 | Veozah |
| Organon LLC | $20.71 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.68 | 2019 | |
| Ethicon US, LLC | $15.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dwight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.